Picture of IGC Pharma logo

IGC IGC Pharma Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSucker Stock

Annual cashflow statement for IGC Pharma, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
2025
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-8.81-15-11.5-13-7.12
Depreciation
Non-Cash Items0.8274.373.015.271.78
Unusual Items
Other Non-Cash Items
Changes in Working Capital-3.292.540.7941.89-0.072
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-10.8-7.46-7.05-5.2-4.79
Capital Expenditures-1.59-0.742-0.619-0.515-0.482
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items4.9800.3840.1980.04
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Cash from Investing Activities3.39-0.742-0.235-0.317-0.442
Financing Cash Flow Items0.50
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities14.74.140.13.524.45
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash7.29-4.09-7.26-2-0.793